Authorized Representative Services

Flowchart for determining eligibility under the extended MDR transitional period for Devices


The Commission just published a Flowchart to assist manufacturers and stakeholders in determining device coverage under the extended transitional period of the MDR

The purpose of the flowchart is to aid manufacturers and other relevant stakeholders in making a determination about the inclusion of a device within the extended transitional period outlined in Article 120 of Regulation (EU) 2017/745 on medical devices (MDR), as revised by Regulation 2023/607. This flowchart is designed to facilitate the assessment of whether certain devices meet the criteria, adhere to the stipulated conditions, and meet the specified deadlines for the placing on the market or putting into service as outlined in Article 120 of the MDR. 

While using the flowchart you are advised to refer to the MDR text, which holds precedence over the flowchart, as well as to consult the Q&A addressing practical aspects related to the implementation of Regulation (EU) 2023/607. 

MDSS provides assistance in going through the flow chart or the Q&A to ensure the accurate application of the extension and the establishment and availability of the relevant documentation, which may be requested by authorities and other parties such as importers. 

Book your appointment here!

Add Comment

* Required information
1000
Captcha Image
Powered by Commentics

Comments

No comments yet. Be the first!
  • UK Responsible Person

    6 Wilmslow Road, Rusholme, Manchester M14 5TP, UK

    +44 7898 375115

  • U.S. Agent

    Chicago
    IL 60630
    USA

    +1 (312) 975-1694

  • Cosmetics Responsible Person

    Schiffgraben 41
    30175 Hannover
    Germany

    +49 511 6262 8630

  • CH-REP

    Laurenzenvorstadt 61
    5000 Aarau
    Switzerland

  • Importer

    Limmerstraße 15
    30451 Hannover
    Germany

    +49 511 62 62 86 30

MDSS GmbH

Schiffgraben 41
30175 Hannover
Germany

Share

Stay informed